Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

EPOR antibody

This Mouse Monoclonal antibody specifically detects EPOR in FACS and cELISA. It exhibits reactivity toward Human and has been mentioned in 2+ publications.
Catalog No. ABIN1720915

Quick Overview for EPOR antibody (ABIN1720915)

Target

EPOR (Erythropoietin Receptor (EPOR))

Reactivity

  • 120
  • 49
  • 47
  • 8
  • 4
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
Human

Host

  • 107
  • 26
  • 4
  • 1
Mouse

Clonality

  • 113
  • 24
  • 1
Monoclonal

Conjugate

  • 81
  • 13
  • 8
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This EPOR antibody is un-conjugated

Application

  • 108
  • 43
  • 42
  • 34
  • 27
  • 25
  • 20
  • 14
  • 14
  • 5
  • 5
  • 5
  • 4
  • 2
  • 2
  • 1
Flow Cytometry (FACS), Cell-ELISA (cELISA)

Clone

VP-2E8
  • Specificity

    Anti-human Epo-R

    Characteristics

    Selection: Based on recognition of the complete native protein expressed on transfected mammalian cells

    Purification

    Protein G

    Immunogen

    genetic immunisation with cDNA encoding the ECD of human Epo-R

    Isotype

    IgG1
  • Application Notes

    Flow cytometry: 1.2 µg/10^6 cells
    ELISA: 1:200 - 1:400
    CELISA: 1:200 - 1:400
    For each application a titration should be performed to determine the optimal concentration.

    Comment

    Synonyms: Erythropoietin receptor

    Restrictions

    For Research Use only
  • Buffer

    PBS, pH 7.2

    Handling Advice

    Avoid repeated freezing and thawing.

    Storage

    4 °C

    Storage Comment

    short term: 2 °C - 8 °C, long term: -20 °C
  • Maxwell, Melendez-Rodríguez, Matchett, Aragones, Ben-Califa, Jaekel, Hengst, Lindner, Bernardini, Brockmeier, Fandrey, Grunert, Oster, Mittelman, El-Tanani, Thiersch, Schneider Gasser, Gassmann et al.: "Novel antibodies directed against the human erythropoietin receptor: creating a basis for clinical implementation. ..." in: British journal of haematology, Vol. 168, Issue 3, pp. 429-42, (2015) (PubMed).

    Hedley, Allan, Xenocostas: "The role of erythropoietin and erythropoiesis-stimulating agents in tumor progression." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 17, Issue 20, pp. 6373-80, (2011) (PubMed).

  • Target

    EPOR (Erythropoietin Receptor (EPOR))

    Alternative Name

    EPOR

    Background

    Erythropoietin receptor (Epo-R) belongs to the cytokine receptor family and is a 507 amino acid type I transmembrane protein. EpoR pre-exists as dimers which changes the homodimerized state after binding of its 34 kDa ligand erythropoietin (Epo). Erythropoietin is the primary regulator of erythropoiesis, and promotes the survival, proliferation, and differentiation of erythroid progenitor cells. Both, Epo and Epo-R are essential for the production of red blood cells due to Epo exerts its function through the Epo receptor. The Epo-R is also expressed in many organs outside the bone marrow, suggesting that Epo is a pleiotropic anti-apoptotic factor. Signaling pathways have been shown to influence numerous cellular functions in normal and tumor cells, including proliferation, apoptosis, and drug resistance.

    UniProt

    P19235

    Pathways

    JAK-STAT Signaling
You are here:
Chat with us!